Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jul 18;17(7):e88267.
doi: 10.7759/cureus.88267. eCollection 2025 Jul.

Extraocular Sebaceous Carcinoma in Lynch Syndrome: A Sentinel Cutaneous Clue to Muir-Torre Syndrome

Affiliations
Case Reports

Extraocular Sebaceous Carcinoma in Lynch Syndrome: A Sentinel Cutaneous Clue to Muir-Torre Syndrome

Suyog S Dhamale et al. Cureus. .

Abstract

Sebaceous carcinoma (SC) is a rare and aggressive cutaneous malignancy, most commonly arising in the periocular region. Extraocular presentations, particularly in patients with Lynch syndrome (LS), are uncommon but clinically significant. We report the case of a 70-year-old male with a known diagnosis of LS and a strong family history of visceral malignancies, who presented with a rapidly enlarging lesion on the forehead. Histopathological examination confirmed extraocular sebaceous carcinoma with a high Ki-67 proliferative index. The lesion was managed successfully with Mohs micrographic surgery (MMS) to ensure complete excision and minimize recurrence. This case fulfilled clinical and molecular criteria for Muir-Torre syndrome (MTS), a phenotypic variant of LS characterized by sebaceous neoplasms and internal malignancies. It underscores the importance of recognizing cutaneous markers of hereditary cancer syndromes and emphasizes the need for prompt dermatological and genetic evaluation in at-risk individuals. Early intervention facilitates timely treatment and familial cancer surveillance.

Keywords: cutaneous malignancy; extraocular; lynch syndrome; mohs micrographic surgery; muir-torre syndrome; sebaceous carcinoma.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. A solitary, pedunculated, hyperkeratotic mass (black arrow) over the superior aspect of medial end of right eyebrow
Figure 2
Figure 2. Histopathology (H&E, 10X)
Scanner view depicting lobules of tumor cells with peripheral squamous differentiation (black arrow) and central tumor cells showing sebaceous morphology (green arrow)
Figure 3
Figure 3. Histopathology (H&E, 40X)
High-power view illustrating tumor cells with abundant eosinophilic to foamy cytoplasm, characteristic of sebaceous differentiation
Figure 4
Figure 4. Immunohistochemistry for Ki-67 showing a high labeling index of 60% within malignant cells (black arrow)

References

    1. A retrospective review of 1349 cases of sebaceous carcinoma. Dasgupta T, Wilson LD, Yu JB. Cancer. 2009;115:158–165. - PubMed
    1. Sebaceous carcinoma: review of the literature. Kyllo RL, Brady KL, Hurst EA. Dermatol Surg. 2015;41:1–15. - PubMed
    1. Muir-Torre syndrome. Ponti G, Ponz de Leon M. Lancet Oncol. 2005;6:980–987. - PubMed
    1. Ocular and extraocular sebaceous carcinomas: a retrospective study with emphasis on the presence of in situ lesion and discussion and review of the histogenesis of extraocular sebaceous carcinoma. Takeuchi D, Ishida M, Yasuda E, Ueda K, Hirose Y. Oncol Lett. 2023;26:337. - PMC - PubMed
    1. The significance of DNA mismatch repair genes in the diagnosis and management of periocular sebaceous cell carcinoma and Muir-Torre syndrome. Gaskin BJ, Fernando BS, Sullivan CA, Whitehead K, Sullivan TJ. Br J Ophthalmol. 2011;95:1686–1690. - PubMed

Publication types

LinkOut - more resources